What does the evidence say about Cranberry Blood Pressure Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Cranberry Blood Pressure Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Overall, the findings suggest that cranberry supplementation notably reduced BMI, particularly among older adults, overweight individuals, and participants who engaged in the intervention for more than 8 weeks. [Tavakoli S (2026); evidence level 1] - This study aimed to review the literature on studies that evaluated the effects of Cranberry consumption on body weight (BW) and liver enzymes in humans. [Tavakoli S (2026); evidence level 1] - The following databases were searched up to December 2024: PubMed/Medline, Scopus, ISI Web of Science, Embase, Cochrane Library, and Google Scholar. [Tavakoli S (2026); evidence level 1] - Stratified analysis showed that the reduction in SBP was statistically significant in studies where cranberry was provided in juice form, with a duration of 8 weeks or less, involving participants with a mean age of Conclusion This systematic review and meta-analysis suggest that cranberry consumption was not effective in managing SBP and DBP. [Bahreyni LZ (2026); evidence level 1] - Background The aim of this paper, which includes a meta-analysis, is to elucidate the effects of cranberry consumption on systolic and diastolic blood pressure based on all relevant randomized controlled trials (RCTs). [Bahreyni LZ (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.